(Q73897239)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

K C Gorson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A H Ropper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D H Weinberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R Weinstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

778-786

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features

7 November 2019

cites work

1 reference

Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide

21 January 2018

1 reference

High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

Polyneuropathy with monoclonal gammopathy: Studies of 11 patients

21 January 2018

1 reference

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

21 January 2018

1 reference

The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.

21 January 2018

1 reference

Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases

21 January 2018

1 reference

Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange.

21 January 2018

1 reference

Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy

21 January 2018

1 reference

Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia

21 January 2018

1 reference

Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein

21 January 2018

1 reference

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

21 January 2018

1 reference

Distal acquired demyelinating symmetric neuropathy

21 January 2018

1 reference

Polyneuropathies associated with IgM monoclonal gammopathies

21 January 2018

1 reference

21 January 2018

1 reference

A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM.

21 January 2018

1 reference

A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group

21 January 2018

1 reference

Polyneuropathy in Waldenstr�m's macroglobulinaemia: Reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis

21 January 2018

1 reference

Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein

21 January 2018

1 reference

Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy

21 January 2018

1 reference

Impact of neurologic signs and symptoms on functional status in peripheral neuropathies

21 January 2018

1 reference

Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy

21 January 2018

1 reference

Treatment of patients with neuropathy and anti-MAG IgM M-proteins

21 January 2018

1 reference

Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.

21 January 2018

1 reference

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies

21 January 2018

1 reference

Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group

21 January 2018

1 reference

Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein

21 January 2018

1 reference

Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation

21 January 2018

1 reference

Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening

21 January 2018

1 reference

Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.

21 January 2018

1 reference

The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study.

21 January 2018

1 reference

Peripheral neuropathy associated with plasma cell dyscrasia: a clinical and electrophysiological follow-up study

21 January 2018

1 reference

Immunofluorescence study of patients with neuropathy and IgM M proteins

21 January 2018

1 reference

Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein

21 January 2018

1 reference

Anti-MAG and anti-SGPG antibodies in neuropathy

21 January 2018

1 reference

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies

21 January 2018

1 reference

Successful management of paraprotein-associated peripheral polyneuropathies by immunoadsorption of plasma with staphylococcal protein A

21 January 2018

1 reference

Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia

21 January 2018

1 reference

Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies

21 January 2018

1 reference

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.1069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11360261%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference